Clinical Trials

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04024462 2026-02-20

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

200 enrolled 16 charts

HER2-positive Early Breast Cancer

NCT06135714 2026-02-11

OLIGAMI

Phase 3 Recruiting

340 enrolled

Breast Neoplasms

NCT05415215 2026-02-10

ProHer

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT02926911 2026-01-27

COMET

997 enrolled 16 charts

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT05278741 2025-12-26

BREAST

32 enrolled

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

84 enrolled 17 charts

Phase NA Not yet recruiting

Breast Neoplasms

NCT07253168 2025-11-28

TIGER-BC

240 enrolled

Breast Neoplasms

NCT05890677 2025-11-14

LYMPH

Phase NA Recruiting

280 enrolled

Breast Cancer Lymphedema

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Phase 3 Recruiting

2,400 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT07016399 2025-10-30

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Phase 2 Recruiting

51 enrolled

Triple Negative Breast Neoplasms

NCT07071402 2025-08-15

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

Phase NA Recruiting

120 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT03725059 2025-07-11

KEYNOTE-756

1,240 enrolled

Breast Neoplasms

NCT06666517 2025-03-13

PERICAFS

69 enrolled

Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT06716073 2024-12-04

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Phase NA Recruiting

1,380 enrolled

Breast Cancer Invasive

NCT00182728 2024-10-01

NRR

89 enrolled 10 charts

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01015625 2024-08-19

POSYTIVE

90 enrolled 16 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03493854 2024-06-26

FeDeriCa

500 enrolled 28 charts 2 FDA

Breast Neoplasms

NCT04997941 2024-04-23

MORE-T

238 enrolled

Premenopausal Breast Cancer

NCT03272477 2024-04-17

TP-II

257 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT03595592 2024-03-06

APTneo

650 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Invasive Breast Cancer

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01717131 2024-01-11

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

2,228 enrolled

Invasive Breast Cancer

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT06121557 2023-11-08

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1 Recruiting

24 enrolled

Breast Neoplasms

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1/2 Recruiting

170 enrolled

Breast Neoplasms

NCT02586025 2023-05-22

PEONY

329 enrolled 33 charts

Breast Neoplasms

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

320 enrolled

Breast Neoplasms

NCT03578380 2023-04-18

Supermicrosurgery for Breast Cancer Survivors With Lymphedema.

Phase NA Unknown

100 enrolled

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

358 enrolled

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Phase 2 Recruiting

74 enrolled

Breast Neoplasms

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

216 enrolled

Breast Cancer Invasive

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

10 enrolled 12 charts

Breast Neoplasms

NCT00309569 2020-10-14

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

429 enrolled

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast Neoplasms

NCT00193778 2020-10-08

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

350 enrolled

Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

100 enrolled

Breast Neoplasms

NCT04066790 2020-05-19

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Terminated

12 enrolled

Breast Neoplasms

NCT04086394 2020-02-20

PECS

Phase NA Unknown

130 enrolled

Breast Neoplasms, Pain, Pain, Postoperative

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

32 enrolled 7 charts

Breast Neoplasms

NCT01142778 2018-03-16

AVATAXHER

152 enrolled

Breast Neoplasms

NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase 1 Completed

28 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT00855114 2017-12-02

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Breast Neoplasms

NCT00450723 2017-02-07

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

39 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast Neoplasms

NCT00003050 2014-05-22

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

46 enrolled

Breast Neoplasms

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

101 enrolled 16 charts